With tirzepatide, the usual starting dose is 2.5 mg once weekly, with increases every ~4 weeks if tolerated, up to a maintenance dose of 5-15 mg weekly for weight loss
Qsymia (phentermine and topiramate): Combining the anticonvulsant topiramate, which has an appetite-suppressing effect, and the stimulant phentermine, Qsymia is FDA approved for chronic weight management
Both the brand name Wegovy, Ozempic, and generic form Semaglutide can all help you lose 15 percent of your body weight or more
How Ozempic became a celebrity weight loss sensation
Due to various factors, some people face premature aging as well for which they start looking for ways to treat
In phase III: Semaglutide 2.4 mg (STEP-1): nausea 44.2%, diarrhea 31.5%, vomiting 24.8% Tirzepatide 15 mg (SURMOUNT-1): nausea 29.2%, diarrhea 23.0%, constipation 16.8% Retatrutide 12 mg (TRIUMPH-1): nausea 37.2%, vomiting 22.0%, diarrhea 27.1% Key observation: tirzepatide shows the most favorable GI profile at equivalent dose, likely tied to the GIP component dampening GLP-1-mediated nausea signaling at the brainstem level
